Johns Hopkins University, home to considerable expertise in RNA sciences and therapeutic development, has announced a new academic collaboration with TriLink BioTechnologies, part of Maravai LifeSciences, designed to accelerate transformational research in RNA therapeutics and discovery. This includes the creation of a new center in the university’s Whiting School of Engineering and access to TriLink’s leading RNA synthesis technology, which will accelerate research and therapeutic development.